CTNM EBIT

Annual EBIT

$23.38 M
+$47.24 M+197.96%

December 31, 2023

Summary

Performance

1-Year Change

+197.96%

3-Year Change

+181.54%

5-Year Change

+181.54%

15-Year Change

+181.54%

CTNM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.45%
CTNM annual earnings before interest & taxes is higher than 85.45% of companies in Healthcare sector

High & Low

All-time High

$23.38 M
CTNM annual earnings before interest & taxes is currently at an all-time high

3-Year Low

-$28.67 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CTNM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
CTNM next annual earnings announcement is scheduled for Feb 28, 2025

OtherCTNMprofitabilitymetrics:

Annual Revenue

$50.00 M
CTNM annual revenue is $50.00 million

Annual Net Income

$22.72 M
CTNM annual net profit is $22.72 million

Annual EBITDA

$23.57 M
CTNM annual EBITDA is $23.57 million

Annual EPS

$1.12
CTNM annual earnings per share is $1.12

Quarterly EBIT

-$10.27 M
-$1.26 M-13.96%

September 30, 2024

Summary

Performance

3-Month Change

-13.96%

1-Year Change

-29.47%

3-Year Change

-38.54%

5-Year Change

-38.54%

CTNM Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.22%
CTNM quarterly earnings before interest & taxes is higher than 38.22% of companies in Healthcare sector

High & Low

All-time High

$42.41 M
CTNM quarterly earnings before interest & taxes is currently -124.21% below its historical high of $42.41 million

3-Year Low

-$10.27 M
CTNM quarterly earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CTNM next earnings announcement is scheduled for Feb 28, 2025

OtherCTNMprofitabilitymetrics:

Quarterly Revenue

-
CTNM quarterly revenue value is unknown

Quarterly Net Income

-$10.27 M
CTNM quarterly net profit is -$10.27 million

Quarterly EBITDA

-$10.21 M
CTNM quarterly EBITDA is -$10.21 million

Quarterly EPS

-$0.40
CTNM quarterly earnings per share is -$0.40

TTM EBIT

-$35.62 M
-$3.90 M-12.29%

September 30, 2024

Summary

Performance

3-Month Change

-12.29%

1-Year Change

-252.38%

3-Year Change

-380.68%

5-Year Change

-380.68%

CTNM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

41.86%
CTNM TTM earnings before interest & taxes is higher than 41.86% of companies in Healthcare sector

High & Low

All-time High

$30.27 M
CTNM TTM earnings before interest & taxes is currently -217.70% below its historical high of $30.27 million

3-Year Low

-$35.62 M
CTNM TTM earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CTNM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
CTNM next earnings announcement is scheduled for Feb 28, 2025

OtherCTNMprofitabilitymetrics:

TTM Revenue

-
CTNM TTM revenue value is unknown

TTM Net Income

-$35.46 M
CTNM TTM net profit is -$35.46 million

TTM EBITDA

-$35.40 M
CTNM TTM EBITDA is -$35.40 million

TTM EPS

-$0.42
CTNM TTM earnings per share is -$0.42

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

$23.38 M
CTNM annual earnings before interest & taxes is $23.38 million

Annual Revenue

$50.00 M
CTNM annual revenue is $50.00 million

Annual Cost Of Goods Sold

-
CTNM annual cost of goods sold value is unknown

Annual Operating Expenses

$33.92 M
CTNM annual total operating expenses is $33.92 million

CTNM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+198.0%-29.5%-252.4%
3 y3 years+181.5%-38.5%-380.7%
5 y5 years+181.5%-38.5%-380.7%

CTNM EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+181.5%-124.2%at low-217.7%at low
5 y5-yearat high+181.5%-124.2%at low-217.7%at low
alltimeall timeat high+181.5%-124.2%at low-217.7%at low

Contineum Therapeutics Class A EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$10.27 M(+14.0%)
-$35.62 M(+12.3%)
Jun 2024
-
-$9.01 M(+7.0%)
-$31.73 M(-261.1%)
Mar 2024
-
-$8.42 M(+6.1%)
$19.69 M(-15.8%)
Dec 2023
$23.38 M
-$7.93 M(+24.5%)
$23.38 M(-2.2%)
Sep 2023
-
-$6.37 M(-115.0%)
$23.90 M(-21.0%)
DateAnnualQuarterlyTTM
Jun 2023
-
$42.41 M(-996.2%)
$30.27 M(-349.2%)
Mar 2023
-
-$4.73 M(-36.1%)
-$12.14 M(+63.9%)
Dec 2022
-$23.86 M(-16.8%)
-
-
Dec 2022
-
-$7.41 M
-$7.41 M
Dec 2021
-$28.67 M
-
-

FAQ

  • What is Contineum Therapeutics Class A annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A annual EBIT year-on-year change?
  • What is Contineum Therapeutics Class A quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A quarterly EBIT year-on-year change?
  • What is Contineum Therapeutics Class A TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Contineum Therapeutics Class A?
  • What is Contineum Therapeutics Class A TTM EBIT year-on-year change?

What is Contineum Therapeutics Class A annual earnings before interest & taxes?

The current annual EBIT of CTNM is $23.38 M

What is the all time high annual EBIT for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high annual earnings before interest & taxes is $23.38 M

What is Contineum Therapeutics Class A annual EBIT year-on-year change?

Over the past year, CTNM annual earnings before interest & taxes has changed by +$47.24 M (+197.96%)

What is Contineum Therapeutics Class A quarterly earnings before interest & taxes?

The current quarterly EBIT of CTNM is -$10.27 M

What is the all time high quarterly EBIT for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high quarterly earnings before interest & taxes is $42.41 M

What is Contineum Therapeutics Class A quarterly EBIT year-on-year change?

Over the past year, CTNM quarterly earnings before interest & taxes has changed by -$2.34 M (-29.47%)

What is Contineum Therapeutics Class A TTM earnings before interest & taxes?

The current TTM EBIT of CTNM is -$35.62 M

What is the all time high TTM EBIT for Contineum Therapeutics Class A?

Contineum Therapeutics Class A all-time high TTM earnings before interest & taxes is $30.27 M

What is Contineum Therapeutics Class A TTM EBIT year-on-year change?

Over the past year, CTNM TTM earnings before interest & taxes has changed by -$59.00 M (-252.38%)